Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

NCT06332534 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Upadacitinib

Sponsor

AbbVie